Overview of pharmaclinical

Recent Posts

Article Request

Rationality, Efficacy, Tolerability of Empagliflozin plus Linagliptin Combination for the Management of Type 2 Diabetes Mellitus: A Systematic review of randomized controlled trials and observational studies.

Chenchul S, Varthya SB, R P.Curr Diabetes Rev. 2021 Sep 10. doi: 10.2174/1573399817666210910165402. Online ahead of print.PMID: 34514991

Clin Ter. Sep-Oct 2002;153(5):305-7. Use of ursodeoxycholic acid combined with silymarin in the treatment of chronic ethyl-toxic hepatopathy.

Cytoprotection in the nineties: experience withursodeoxycholic acid and silymarin in chronic liver disease. Lirussi F, Okolicsanyi L. Acta Physiologica Hungarica 1992; , 80(1-4): 363-367

Ann Intern Med . 2021 Oct;174(10):JC110. doi: 10.7326/ACPJ202110190-110. Epub 2021 Oct 5.

In patients with acute HF and iron deficiency, IV ferric carboxymaltose improved quality of life at 4 to 24 wk

Anthony A Donato 1, Jared Green 1

Articel Request Full Text

2. M. L. Li,
“Clinical observation of berberine combined with metformin on treating type 2 diabetes,”
Hubei Journal of Traditional Chinese Medicine, vol. 30, no. 2, pp. 34–35, 2008.

3. L. Qiu, G. H. Sheng, Y. Qu, and S. Y.Wang,
“Clinical efficiency of berberine hydrochloride in type 2 diabetes mellitus and its effect on serum adiponectin and insulin resistance factor levels”
Shanghai Medical Journal, vol. 34, no. 9, pp. 679–681, 2011

4. Z. X. Sheng and D. H. Xie,
“Therapeutic effect of berberine on the levels of inflammatory factors in type 2 diabetic patients,”
New Medicine, vol. 41, no. 3, pp. 177–180, 2010